Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings
1. Abbott Laboratories reported Q1 adjusted EPS of $1.09, beating expectations. 2. Q1 sales reached $10.36 billion, up 7.2% year-over-year. 3. Guidance for Q2 adjusted EPS is $1.23-$1.27, in line with consensus.